AmatoMPDe StefanoNIngleseM, et al. Secondary prevention in radiologically isolated syndromes and prodromal stages of multiple sclerosis. Front Neurol2022; 13: 787160.
2.
OkudaDTMowryEMBeheshtianA, et al. Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome [Internet]. Neurology2009; 72: 800–805, www.neurology.org
3.
OkudaDTSivaAKantarciO, et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS ONE2014; 9(3): e90509.
4.
Lebrun-FrenayCKantarciOSivaA, et al. Radiologically isolated syndrome: 10-year risk estimate of a clinical event. Ann Neurol2020; 88(2): 407–417.
5.
ThompsonAJBanwellBLBarkhofF, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17: 162–173.
6.
IngleseMPetraccaM. MRI in multiple sclerosis: Clinical and research update. Curr Opin Neurol2018; 31(3): 249–255.
7.
OkudaDTKantarciOLebrun-FrénayC, et al. Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome. Ann Neurol2023; 93(3): 604–614.
8.
HartungDM. Health economics of disease-modifying therapy for multiple sclerosis in the United States. Ther Adv Neurol Disord2021; 14: 987031.
9.
De StefanoNGiorgioATintoréM, et al. Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations. Mult Scler2018; 24(2): 214–221.
